Alcon posts results of Phase 3 apraclonidine study for ocular redness
The study enrolled 159 participants and was completed on November 14, 2024. Results were first posted on ClinicalTrials.gov on November 10, 2026.
Primary source
ClinicalTrials.gov results record, November 10, 2026
A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness
Read the source: A Double-Masked Comparison of FID 123320 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness clinicaltrials.gov
Machine-summarized from the source above; not independently reported. How we use automation